Summary
Eli Lilly and Company (LLY) filed an 8-K on December 15, 2016, to update its financial guidance. The company provided revised financial expectations for the remainder of 2016 and issued initial guidance for 2017. This filing also reaffirmed Lilly's financial outlook through the end of the decade, indicating confidence in its long-term strategy and growth prospects. The company emphasized its use of non-GAAP financial measures, which exclude items such as amortization of intangibles and other variable or unpredictable expenses. Lilly stated that these non-GAAP measures are intended to provide investors with a clearer view of ongoing operations and facilitate meaningful comparisons across periods, helping to identify underlying operational trends. Management also uses these metrics for internal performance evaluation and resource allocation.
Key Highlights
- 1Eli Lilly updated its 2016 financial guidance.
- 2Initial financial guidance for 2017 was provided.
- 3The company reaffirmed its financial expectations through the end of the decade.
- 4A press release detailing the guidance updates was issued on December 15, 2016.
- 5A teleconference was held to discuss the financial guidance with analysts and media.
- 6Lilly highlighted its use of non-GAAP financial measures to offer insights into ongoing operations.